Walleye Trading
BIO icon

Walleye Trading’s Bio-Rad Laboratories Class A BIO Stock Holding History

Walleye Trading’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,000
Closed -$969K – 4775
2023
Q4 		$969K Buy
+3,000
New +$940K ﹤0.01% 2494
2022
Q2 		– Sell
-100
Closed -$56K – 5129
2022
Q1 		$56K Sell
100
-700
-88% -$422K ﹤0.01% 4470
2021
Q4 		$604K Buy
800
+300
+60% +$225K ﹤0.01% 2756
2021
Q3 		$373K Buy
500
+100
+25% +$74.9K ﹤0.01% 3219
2021
Q2 		$258K Hold
400
– – ﹤0.01% 3663
2021
Q1 		$228K Sell
400
-2,300
-85% -$1.36M ﹤0.01% 3494
2020
Q4 		$1.57M Buy
2,700
+1,800
+200% +$1.03M 0.01% 1595
2020
Q3 		$464K Sell
900
-100
-10% -$50.6K ﹤0.01% 2306
2020
Q2 		$451K Sell
1,000
-200
-17% -$88.3K ﹤0.01% 2353
2020
Q1 		$421K Sell
1,200
-300
-20% -$110K ﹤0.01% 1990
2019
Q4 		$555K Buy
1,500
+800
+114% +$282K ﹤0.01% 2321
2019
Q3 		$233K Sell
700
-7,400
-91% -$2.41M ﹤0.01% 2818
2019
Q2 		$2.53M Buy
+8,100
New +$2.43M 0.02% 878

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Walleye Trading's BIO Position: Q4 2022 in Review

Walleye Trading sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2022, closing a stake of 918 shares — an estimated $383K sold.

Walleye Trading first reported a position in BIO in Q2 2015 and held it in 14 quarters. The position peaked at $592K in Q4 2021. 470 funds tracked by Wall St. Rank hold BIO as of Q4 2022.

  • Walleye Trading reported no remaining Bio-Rad Laboratories Class A position as of Q4 2022 after selling out during the quarter.
  • Walleye Trading sold 918 Bio-Rad Laboratories Class A shares in Q4 2022, an estimated $383K.
  • Walleye Trading first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and held it in 14 quarters.
  • Walleye Trading's Bio-Rad Laboratories Class A position peaked at $592K in Q4 2021.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.